Title : Design of a Multicompartment Hydrogel that Facilitates Time-Resolved Delivery of Combination Therapy and Synergized Killing of Glioblastoma.

Pub. Date : 2018 Nov 12

PMID : 30240496






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This material architecture effectively delivers the EGFR kinase inhibitor Erlotinib (ERL) and Doxorubicin (DOX, DNA intercalator) in an ERL DOX sequential manner to synergistically kill glioblastoma, the most aggressive form of brain cancer. Doxorubicin epidermal growth factor receptor Homo sapiens